MaineLD 538132nd Maine Legislature (2025-2026)House

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

Sponsored By: Sally Cluchey (Democratic)

Signed by Governor

PRESCRIPTION DRUGSPRESCRIPTION DRUGS - REGULATION

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Clinic name on mifepristone and misoprostol labels

The law lets a prescriber ask the pharmacy to list the clinic or health care facility on the label instead of the prescriber’s name. This option applies only to mifepristone, misoprostol, and their generic versions. All other label details stay the same, like the patient’s name, directions, drug name and strength, beyond-use date, and pharmacy contact. The prescriber must make the request.

Sponsors & Cosponsors

Sponsor

  • Sally Cluchey

    Democratic • House

Cosponsors

  • Amy Kuhn

    Democratic • House

  • Anne M. Carney

    Democratic • Senate

  • Cassie Julia

    Democratic • House

  • Donna Bailey

    Democratic • Senate

  • Kristi Mathieson

    Democratic • House

  • Lori Gramlich

    Democratic • House

  • Matt Moonen

    Democratic • House

  • Ryan Fecteau

    Democratic • House

  • Sophia Warren

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 94 • No: 84

Senate vote • 5/21/2025

ACCEPT MAJORITY OUGHT TO PASS AS AMENDED REPORT

Yes: 19 • No: 13

House vote • 5/20/2025

ACC MAJ OTP AS AMENDED REP

Yes: 75 • No: 71

Actions Timeline

  1. Signed by Governor, ACTPUB Chapter 142

    5/29/2025
  2. PASSED TO BE ENACTED, in concurrence.

    5/27/2025Senate
  3. PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.

    5/27/2025House
  4. Reports ReadOn motion by Senator BAILEY of York the Majority Ought to Pass as Amended Report ACCEPTED. PREVAILED Roll Call Ordered Roll Call Number 198 Yeas 19 - Nays 13 - Excused 3 - Absent 0 Bill READ ONCE Committee Amendment "A" (H-179) READ and ADOPTED Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (H-179) in concurrence.

    5/21/2025Senate
  5. Reports READ.On motion of Representative MATHIESON of Kittery, the Majority Ought to Pass as Amended Report was ACCEPTED.ROLL CALL NO. 148(Yeas 75 - Nays 71 - Absent 4 - Excused 0 - Restricted - 1)The Bill was READ ONCE.Committee Amendment "A" (H-179) was READ and ADOPTED.Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-179). Sent for concurrence. ORDERED SENT FORTHWITH.

    5/20/2025House
  6. Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.

    3/21/2025House
  7. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence

    2/11/2025Senate
  8. Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.Sent for concurrence. ORDERED SENT FORTHWITH.

    2/11/2025House

Bill Text

  • Amendment C-A (H-179), adopted by House & Senate

  • Enacted

  • Introduced

Related Bills

Back to State Legislation